Icon, a Dublin-based company that provides clinical-development support services to drug, biotechnology and medical-device companies, has acquired Zurich-based Timaq Medical Imaging.
Icon acquires Timaq Medical Imaging
Financial terms of the deal have not been disclosed, but the acquisition is expected to broaden services offered by Icon Medical Imaging, a division of Icon, according to a news release. Icon Medical Imaging provides medical-imaging-based product development and clinical-trial services.
“The acquisition of Timaq will complement our existing U.S. operations by giving Icon a European base for our medical-imaging operations,” said Icon Medical Imaging President Ted Gastineau.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.